One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis-A Multicentre Real-World Experience.

ABSTRACT:

Background

Bicuspid aortic valve (BAV) affects approximately 1.5% of the general population and is seen in nearly 50% of candidates for aortic valve replacement (AVR). Despite increasingly utilised transcatheter aortic valve implantation (TAVI) in aortic stenosis (AS) patients, its use among patients with severe bicuspid AS is limited as BAV is a heterogeneous disease associated with multiple and complex anatomical challenges.

Aim

To investigate the one-year outcomes of TAVI using the balloon-expandable Myval transcatheter heart valve (THV) (Meril Life Sciences Pvt. Ltd., Vapi, India) in patients with severe bicuspid AS.

Methods and results

We collected data from consecutive patients with bicuspid AS who underwent TAVI with the Myval THV and had at least one-year foll

SUBMITTER: Elkoumy A 

PROVIDER: S-EPMC10054138 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature